Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000272286 | SCV000340571 | uncertain significance | not provided | 2016-04-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000272286 | SCV001207115 | uncertain significance | not provided | 2024-12-02 | criteria provided, single submitter | clinical testing | This sequence change affects codon 666 of the PCDH15 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the PCDH15 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs754253198, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with PCDH15-related conditions. ClinVar contains an entry for this variant (Variation ID: 286959). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001828238 | SCV002088533 | uncertain significance | Usher syndrome type 1F | 2019-11-11 | no assertion criteria provided | clinical testing |